Your browser doesn't support javascript.
loading
Laboratory Investigation of Myeloproliferative Neoplasms (MPNs): Recommendations of the Canadian Mpn Group.
Busque, Lambert; Porwit, Anna; Day, Radmila; Olney, Harold J; Leber, Brian; Éthier, Vincent; Sirhan, Shireen; Foltz, Linda; Prchal, Jaroslav; Kamel-Reid, Suzanne; Karsan, Aly; Gupta, Vikas.
Afiliação
  • Busque L; From the Department of Laboratory Hematology, Hôpital Maisonneuve-Rosemont, Universté De Montréal, Montréal, Quebec, Canada lbusque.hmr@ssss.gouv.qc.ca vikas.gupta@uhn.ca.
  • Porwit A; Department of Pathology, University Health Network Department of Laboratory Medicine and Pathobiology.
  • Day R; Fusion MD Medical Science Network, Montréal, Quebec, Canada.
  • Olney HJ; Department of Hematology and Transfusional Medicine, Centre Hospitalier De L'Université De Montréal, Montréal, Quebec, Canada.
  • Leber B; Department of Medicine, Hematology and Thromboembolism, McMaster University, Hamilton, Ontario, Canada.
  • Éthier V; From the Department of Laboratory Hematology, Hôpital Maisonneuve-Rosemont, Universté De Montréal, Montréal, Quebec, Canada.
  • Sirhan S; Division of Hematology, Jewish General Hospital, Montréal, Quebec, Canada.
  • Foltz L; Division of Hematology, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Prchal J; Department of Oncology, McGill University, Montréal, Quebec, Canada.
  • Kamel-Reid S; Department of Pathology, University Health Network Department of Laboratory Medicine and Pathobiology.
  • Karsan A; Pathology & Laboratory Medicine and Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Gupta V; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada lbusque.hmr@ssss.gouv.qc.ca vikas.gupta@uhn.ca.
Am J Clin Pathol ; 146(4): 408-22, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27686169
OBJECTIVES: To standardize diagnostic investigations for myeloproliferative neoplasms (MPNs) to increase homogeneity in patient care and to streamline diagnostic approaches in the most efficient and cost-effective manner. METHODS: The development of Canadian expert consensus recommendations for the diagnosis of MPNs began with a review of the following: clinical evidence, daily practice, existing treatment guidelines, and availability of diagnostic tools. Each group member was assigned a specific topic, which they discussed with the entire group during several consensus meetings. RESULTS: This document provides the Canadian MPN group's recommendations, proposed diagnostic algorithms, and background evidence upon which decisions were made. CONCLUSIONS: Standardization of diagnostic investigations will increase homogeneity in patient care and provide a foundation for future clinical research in this rapidly evolving therapeutic area. Streamlining diagnostic approaches in the most efficient and cost-effective manner will also result in significant cost saving for the health care system.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Am J Clin Pathol Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Am J Clin Pathol Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido